Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
(CH)
ATC Code
L01ED03
Source
SWISSMEDIC
(
ARTG
)
Adjuvant treatment of resected non-small cell lung cancer,Alecensa is indicated as adjuvant treatment in adult patients following tumour resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours equal to or greater than 4 cm or node positive).,Treatment of metastatic NSCLC,Alecensa is indicated for the treatment of patients with ALK-positive, locally advanced or metastatic NSCLC.
PillsCard reference image